Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536666/ |